Nath Bio-Genes
196.01
+15.22(+8.42%)
Market Cap₹372.50 Cr
PE Ratio7.59
IndustryFMCG
Company Performance:
1D+8.42%
1M+50.45%
6M+15.87%
1Y+24.20%
5Y-44.02%
View Company Insightsright
More news about Nath Bio-Genes
11Jul 25
Nath Bio-Genes Reports Strong Q1 FY2026 Results with 12.7% Profit Growth
Nath Bio-Genes (India) Limited announced strong Q1 FY2026 results with revenue increasing 14.9% to ₹280.17 crore and net profit rising 12.7% to ₹38.21 crore compared to the same period last year. Operating profit grew 4.7% to ₹37.93 crore. The company's Board approved the appointment of Ms. Payal Jain as an Additional Director, pending shareholder approval for her role as Independent Director.
 no imag found
Nath Bio-Genes
196.01
+15.22
(+8.42%)
1 Year Returns:+24.20%
Industry Peers
LT Foods
430.65
(+1.31%)
KRBL
367.15
(-0.94%)
Kaveri Seed Company
965.35
(+4.28%)
Trualt Bioenergy
492.45
(+1.32%)
GRM Overseas
165.97
(+0.34%)
Sanstar
90.09
(+4.38%)
Gulshan Polyols
181.16
(-0.43%)